Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double‐blind Phase Ib study.

Saved in:
Bibliographic Details
Title: Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double‐blind Phase Ib study.
Authors: Walker, Alex1 (AUTHOR) alex.s.walker@gsk.com, Erwig, Lars1 (AUTHOR), Foster, Katie1 (AUTHOR), Nevin, Katherine1 (AUTHOR), Wenzel, Joerg2 (AUTHOR), Worm, Margitta3 (AUTHOR), Williams, Nicola1 (AUTHOR), Ratia, Nirav1 (AUTHOR), Hoang, Bao4 (AUTHOR), Schneider‐Merck, Tanja5 (AUTHOR), Gisbert, Sophie6 (AUTHOR), Carnarius, Heike5 (AUTHOR), Dickson, Marion1 (AUTHOR)
Source: Experimental Dermatology. Nov2021, Vol. 30 Issue 11, p1686-1692. 7p.
Database: Academic Search Ultimate
Description
ISSN:09066705
DOI:10.1111/exd.14253